Stem Cell Transplant Complications Completed Phase 2 Trials for Fluconazole (DB00196)

IndicationStatusPhase
DBCOND0081111 (Stem Cell Transplant Complications)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03159845Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological MalignanciesSupportive Care